Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Uncertainty and BRCA1[original query] |
---|
A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2002 Nov 21 (6): 564-72. Cella David, Hughes Chanita, Peterman Amy, Chang Chih-Hung, Peshkin Beth N, Schwartz Marc D, Wenzel Lari, Lemke Amy, Marcus Alfred C, Lerman Car |
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast cancer research : BCR 2004 6 (1): R8-R17. Robson Mark E, Chappuis Pierre O, Satagopan Jaya, Wong Nora, Boyd Jeff, Goffin John R, Hudis Clifford, Roberge David, Norton Larry, Bégin Louis R, Offit Kenneth, Foulkes William |
Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation. Genetic testing 2004 8 (1): 13-21. Claes Erna, Evers-Kiebooms Gerry, Boogaerts Andrea, Decruyenaere Marleen, Denayer Lieve, Legius Er |
Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. American journal of medical genetics. Part A 2004 Feb 124A (4): 346-55. van Roosmalen Mariëlle S, Stalmeier P F M, Verhoef L C G, Hoekstra-Weebers J E H M, Oosterwijk J C, Hoogerbrugge N, Moog U, van Daal W A |
Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Feb 15 (3): 1112-20. Agalliu Ilir, Gern Robert, Leanza Suzanne, Burk Robert |
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 2009 May 115 (10): 2222-33. Hall Michael J, Reid Julia E, Burbidge Lynn A, Pruss Dmitry, Deffenbaugh Amie M, Frye Cynthia, Wenstrup Richard J, Ward Brian E, Scholl Thomas A, Noll Walter |
Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing. Cancer prevention research (Philadelphia, Pa.) 2010 Dec 3 (12): 1579-85. Hall Michael J, Reid Julia E, Wenstrup Richard |
Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genetics in medicine : official journal of the American College of Medical Genetics 2011 1 13 (2): 148-54. Plon Sharon E, Cooper H Paul, Parks Bethany, Dhar Shweta U, Kelly P Adam, Weinberg Armin D, Staggs Stephanie, Wang Tao, Hilsenbeck Sus |
Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility. BMC medical genomics 2015 8 (1): 72. Piccolo Stephen R, Andrulis Irene L, Cohen Adam L, Conner Thomas, Moos Philip J, Spira Avrum E, Buys Saundra S, Johnson W Evan, Bild Andrea |
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy. Cancer 2016 Apr . Matulonis Ursula A, Harter Philipp, Gourley Charlie, Friedlander Michael, Vergote Ignace, Rustin Gordon, Scott Clare, Meier Werner, Shapira-Frommer Ronnie, Safra Tamar, Matei Daniela, Fielding Anitra, Spencer Stuart, Parry David, Grinsted Lynda, Ledermann Jonathan |
Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes. BJOG : an international journal of obstetrics and gynaecology 2019 9 127 (3): 364-375. Manchanda R, Burnell M, Gaba F, Desai R, Wardle J, Gessler S, Side L, Sanderson S, Loggenberg K, Brady A F, Dorkins H, Wallis Y, Chapman C, Jacobs C, Legood R, Beller U, Tomlinson I, Menon U, Jacobs |
Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis. Breast (Edinburgh, Scotland) 2021 Feb 56 26-34. Davey M G, Davey C M, Ryan É J, Lowery A J, Kerin M |
Communication processes about predictive genetic testing within high-risk breast cancer families: a two-phase study design. Scientific reports 2021 Oct 11 (1): 20178. Blomen Chiara L, Pott Aliaksandra, Volk Alexander E, Budäus Lars, Witzel Isabe |
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders. Journal of medical genetics 2022 11 . Carrasco Estela, López-Fernández Adrià, Codina-Sola Marta, Valenzuela Irene, Cueto-González A M, Villacampa Guillermo, Navarro Victor, Torres-Esquius Sara, Palau Dolors, Cruellas Mara, Torres Maite, Perez-Dueñas Belen, Abulí Anna, Diez Orland, Sábado-Álvarez Constantino, García-Arumí Elena, Tizzano Eduardo F, Moreno Lucas, Balmaña Judi |
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology. Breast (Edinburgh, Scotland) 2022 11 66 293-304. Miglietta Federica, Cinquini Michela, Dieci Maria Vittoria, Cortesi Laura, Criscitiello Carmen, Montemurro Filippo, Del Mastro Lucia, Zambelli Alberto, Biganzoli Laura, Levaggi Alessia, Delle Piane Chiara, Marchiò Caterina, Calabrese Massimo, Fortunato Lucio, Franco Pierfrancesco, Meduri Bruno, Fittipaldo Veronica Andrea, Gori Stefan |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: